Zydus Lifesciences Limited (NSE:ZYDUSLIFE)

India · Delayed Price · Currency is INR

1,140.60

+40.80 (3.71%)

Jul 3, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	224.12B	205.44B	172.35B	149.93B	131.31B
Pharmaceuticals Growth	9.09%	19.20%	14.96%	14.18%	4.53%
Consumer Products	39.54B	26.98B	23.12B	22.45B	19.79B
Consumer Products Growth	46.57%	16.68%	2.99%	13.44%	7.49%
Medical Technologies	7.82B	-	-	-	-
Total	271.48B	232.42B	195.47B	172.37B	151.10B
Total Growth	16.81%	18.90%	13.40%	14.08%	4.90%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	92.53B	80.15B	76.40B	70.98B
India Growth	15.44%	4.91%	7.64%	21.14%
United States	111.41B	87.75B	74.87B	59.49B
United States Growth	26.96%	17.21%	25.86%	-7.75%
Others	28.47B	27.57B	21.11B	20.63B
Others Growth	3.29%	30.61%	2.30%	-1.56%
Total	232.42B	195.47B	172.37B	151.10B
Total Growth	18.90%	13.40%	14.08%	4.90%